Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?
One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification across 251 biotech companies at a cheaper cost.
Overview
The Invesco Pharmaceuticals ETF (NYSEMKT:PJP) offers concentrated exposure to U.S. drugmakers, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) provides a broader, lower-cost gateway to the biotechnology and pharmaceutical sectors.
Both funds target the healthcare space but employ different approaches. PJP focuses on a tight group of 29 pharmaceutical giants, whereas IBBQ tracks the Nasdaq Biotechnology Index, offering exposure to a much wider array of mid- and large-cap firms.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Details
Source
Originally published at www.fool.com.